Adult: 125 to 250 micrograms(0.125 to 0.25 mg) once daily
Reduce the dose by half in older patients and in patients with renal impairment.
Duration
According to clinical response
Contra-indications, adverse effects, precautions
Do not administer to patients with bradycardia, ill defined arrhythmia, coronary artery disease. It is essential to monitor heart rate in the initial stage of treatment.
May cause in the event of overdose: gastrointestinal disturbances (nausea, vomiting, diarrhoea), blurred vision, headache, confusion, conduction and rhythm disorders. If so, reduce dose or stop treatment.
Do not combine with calcium, particularly by IV route (serious arrhythmias).